Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma

18 participants · First posted Jan 11, 2013

Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Male and Female Subjects and Safety, Tolerability, Pharmacokinetics, and Pilot Efficacy Biomarkers in Subjects With Cold Agglutinin Disease

70 participants · First posted Apr 8, 2022

Evaluation of the Motus Gl CleanUp System During Screening Colonoscopy

71 participants · First posted Jun 11, 2014

GL-0001

GL-0719

GL-522

Aponia Laboratories, Inc.

United States

Savonia University of Applied Sciences

Finland

UWM-Developed Drug, GL-Damonia, Enters FDA Phase 1 Trials for Depression and Alzheimer's

GL CHEMTEC Completes State-of-the-Art GMP Facility to Accelerate Clinical Trial Material Production

Genetic Leap Receives FDA IND Clearance for First-in-Class Oral IL-2 Modulator GL-IL2-138